Afshin Fassihi

Orcid: 0000-0002-8042-5986

According to our database1, Afshin Fassihi authored at least 12 papers between 2011 and 2022.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2022
Accelerating Big Data Analysis through LASSO-Random Forest Algorithm in QSAR Studies.
Bioinform., 2022

2021
3D U-Net: A voxel-based method in binding site prediction of protein structure.
J. Bioinform. Comput. Biol., 2021

2020
Protein kinase inhibitors' classification using <i>K</i>-Nearest neighbor algorithm.
Comput. Biol. Chem., 2020

2019
Gp41 inhibitory activity prediction of theaflavin derivatives using ligand/structure-based virtual screening approaches.
Comput. Biol. Chem., 2019

2018
Deep neural network in QSAR studies using deep belief network.
Appl. Soft Comput., 2018

2017
The role of different sampling methods in improving biological activity prediction using deep belief network.
J. Comput. Chem., 2017

2015
Acceleration of MPI mechanisms for sustainable HPC applications.
Supercomput. Front. Innov., 2015

Applications of High Performance Computing in Bioinformatics, Computational Biology and Computational Chemistry.
Proceedings of the Bioinformatics and Biomedical Engineering, 2015

Improving Activity Prediction of Adenosine A2B Receptor Antagonists by Nonlinear Models.
Proceedings of the Bioinformatics and Biomedical Engineering, 2015

2012
Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach.
J. Comput. Aided Mol. Des., 2012

Application of an expert system based on Genetic Algorithm-Adaptive Neuro-Fuzzy Inference System (GA-ANFIS) in QSAR of cathepsin K inhibitors.
Expert Syst. Appl., 2012

2011
Exploring a Model of a Chemokine Receptor/Ligand Complex in an Explicit Membrane Environment by Molecular Dynamics Simulation: The Human CCR1 Receptor.
J. Chem. Inf. Model., 2011


  Loading...